Dame Emma Walmsley has announced her departure as chief executive of GSK, marking the end of a transformative chapter for one of Britain’s most prominent pharmaceutical firms. During her tenure
Dame Emma Walmsley has announced her departure as chief executive of GSK, marking the end of a transformative chapter for one of Britain’s most prominent pharmaceutical firms. During her tenure
Pfizer has completed the sale of its remaining 7% stake in Haleon, the FTSE 100 consumer healthcare company, raising £2.4 billion. This transaction, involving the placement of 618 million shares






